Summary: Researchers have produced the first multiscale atlas of the brain’s histamine system, linking molecular biology and genetics to neuroimaging and behavior. Although histamine is well known for its role in allergic reactions, this work emphasizes its important but underappreciated role as a neurotransmitter that modulates emotion, sleep, memory and cognitive control.
These results offer a new framework to understand how abnormalities in histamine signalling may contribute to conditions such as ADHD, major depression and schizophrenia.
Key Research Findings
- Excitation–Inhibition Balance: Distinct histamine receptors are expressed on both excitatory and inhibitory neurons, implying histamine helps maintain the neural balance crucial for healthy brain activity.
- Cognitive and Emotional Hubs: Brain regions with elevated expression of histamine-related genes are consistently linked to emotional regulation, stress and fear responses, decision-making, reward processing, sleep and memory.
- Overlap with Psychiatric Conditions: Areas with strong histaminergic gene activity overlap significantly with brain regions implicated in ADHD, major depressive disorder, schizophrenia and anorexia nervosa.
- Multiscale Mapping: The atlas was built by integrating gene expression and molecular data with positron emission tomography (PET) imaging and functional neuroimaging databases to capture histamine signalling across levels, from cells to whole-brain systems in living people.
- Therapeutic Opportunities: Because histamine interacts with dopamine and serotonin systems, it represents a promising target for treatments aimed at cognitive deficits, fatigue and reduced motivation that are not always addressed by current medications.
Source: King’s College London
New collaborative research from King’s College London and the University of Porto has mapped the histaminergic system across multiple biological scales. Histamine, a molecule widely associated with allergic responses, also operates in the brain as a neuromodulator whose organization and roles have been incompletely characterized until now.
This study fills that gap by producing the first multiscale map of the histamine system, linking gene and cell-level data to brain-wide activity and behavior, and relating those patterns to psychiatric conditions.
The results introduce a new perspective on how this often-overlooked neurotransmitter supports brain function and suggest directions for developing treatments that target histamine pathways in disorders such as depression, ADHD and schizophrenia.
The study appears in Nature Mental Health and was supported by the NIHR Maudsley Biomedical Research Centre.
Histamine acts as a neurotransmitter that shapes neuronal communication, yet neuroscience has historically focused more heavily on systems like dopamine and serotonin. By combining molecular and imaging techniques, the authors mapped where histamine is produced, where its receptors are expressed, and how this architecture relates to cognition and clinical vulnerability.
Dr Daniel Martins, visiting senior research fellow at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London and first author of the paper, explained that integrating molecular biology, brain imaging and computational analysis provides a foundational view of how neurotransmitter systems are organized across the human brain. He emphasized that understanding systems such as histamine will be important as psychiatry moves toward more integrated and personalized models of mental health.
Histamine signals are received by several receptor types, and the study found distinct receptor distributions at the single-cell level: H1 and H2 receptors were enriched in excitatory neurons, whereas H3 receptor expression was higher in inhibitory cell populations. This receptor-specific localization supports a role for histamine in regulating the balance between excitation and inhibition in cortical circuits.
To create the atlas, researchers combined transcriptomic and molecular maps with anatomical brain atlases to determine which regions receive greater histaminergic input and which are more responsive to histamine. They then correlated these molecular patterns with PET imaging of histamine receptors in living participants and with large functional neuroimaging databases that link brain regions to cognitive processes and psychiatric disorders. PET provides in vivo measures of receptor binding by tracking a small tracer in real time.
Regions with higher histaminergic gene expression consistently mapped to functions such as emotion regulation, salience and threat processing, impulsivity and decision-making, reward, sleep and different forms of memory. Importantly, the spatial distribution of histamine-related expression also aligned with structural changes reported in several psychiatric disorders, reinforcing hypotheses that histaminergic signalling may contribute to regional vulnerability in mental illness.
Dr Martins noted that while current psychiatric medications mainly target serotonin and dopamine systems, histamine modulates those pathways and could be targeted to address symptoms like cognitive impairment, low energy and reduced motivation. He stressed that these findings are correlational and hypothesis-generating rather than proof of causation, reflecting large-scale dataset patterns rather than direct mechanisms.
Professor Steve Williams, Professor of Neuroimaging at IoPPN and senior author of the paper, added that the map opens new research avenues to investigate histamine’s specific roles in different cell types and brain regions. Future work will test how histaminergic signalling changes in living people, using pharmacological challenges and longitudinal imaging.
Dr Daniel Van Wamelen, Clinical Senior Lecturer in Neuroscience at IoPPN and co-author, described ongoing projects such as iMarkHD that use PET to study the H3 receptor in Huntington’s disease, aiming to track histamine activity over time and relate it to symptoms like apathy, depression and anxiety.
Key Questions Answered:
A: Most common antihistamines for allergies are formulated to avoid crossing the blood–brain barrier, which reduces drowsiness. This study concerns the brain’s internal histamine system and its receptors, which regulate alertness, cognition and emotional processing rather than peripheral allergic symptoms.
A: Existing treatments do not benefit everyone. Because histamine interacts with dopamine and serotonin systems, targeting histaminergic pathways could address specific symptoms—such as mental fog, fatigue and low motivation—that are sometimes resistant to standard therapies.
A: The findings support a more modern view: mental health conditions are best understood as disruptions across interacting brain systems rather than a simple deficiency of a single chemical. Histamine appears to be one important component in a complex, interconnected neural network.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The full journal paper was reviewed.
- Additional context was provided by staff.
About this brain mapping and mental health research news
Author: Franca Davenport
Source: King’s College London
Contact: Franca Davenport – King’s College London
Image: Image credit: Neuroscience News
Original Research: Open access. “Mapping Histamine Pathway Networks in the Human Brain Across Cognition and Psychiatric Disorders” by Daniel Martins et al., published in Nature Mental Health. DOI: 10.1038/s44220-026-00637-1
Abstract
Mapping Histamine Pathway Networks in the Human Brain Across Cognition and Psychiatric Disorders
Histamine is a neuromodulator that shapes cognition, emotion and behavioral flexibility, but its organization in the human brain has been incompletely characterized. The authors performed a multimodal analysis that integrates transcriptomic, neuroimaging, developmental and functional datasets to map the architecture of the histaminergic system.
At the single-cell level, H1 and H2 receptors were enriched in excitatory neurons, while H3 receptor expression was preferentially found in inhibitory populations.
Regional expression of core histaminergic genes was summarized by a single latent component explaining 41.1% of variance, with higher expression in frontal and limbic regions and lower expression in occipital cortex. This spatial signature predicted in vivo H3 receptor binding across independent PET datasets.
Functional decoding associated histaminergic expression with emotion regulation, salience processing, impulsivity, sleep, memory and reward. Developmental patterns showed early peaks in histidine decarboxylase expression and increases in H3 receptor expression into adulthood.
Finally, histaminergic expression correlated with structural alteration patterns observed in ADHD, major depressive disorder, schizophrenia and anorexia nervosa, suggesting the system’s relevance for regional vulnerability in psychiatric disorders.